Repository logo

Treating Lows: Management of Orthostatic Hypotension

Accepted version

Change log



Orthostatic hypotension is a prevalent clinical condition, caused by heterogenous aetiologies and associated with significant morbidity and mortality. Management is particularly challenging in patients with uncontrolled hypertension. A thorough assessment is needed to draw an appropriate management plan. The treatment aims to improve postural symptoms while minimising side effects and reducing iatrogenic exacerbation of supine hypertension. A personalised management plan including rationalising medications, patient education, identification, and avoidance of triggers, as well as non-pharmacological therapies such as compression devices, dietary modifications, and postural aids, make the first steps. Among pharmacological therapies, midodrine and fludrocortisone are the most prescribed and best studied; pyridostigmine, atomoxetine, and droxidopa are considered next. Yohimbine remains an investigational agent. A multi-disciplinary team may be required in some patients with multiple comorbidities and polypharmacy. However, there’s a lack of robust efficacy and safety evidence for all therapies. Building robust real-world and stratified clinical trials based on underlying pathophysiology may pave the way for further drug development and better clinical strategies and in this challenging unmet medical need.



Journal Title

Journal of Cardiovascular Pharmacology

Conference Name

Journal ISSN


Volume Title


Lippincott, Williams & Wilkins

Publisher DOI

Publisher URL